Ashland Inc. (ASH) KPIs and segments

ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 6/3023% above fair value

$75.27−1.45 (-1.89%)

Close on Nov 12, 2026Market cap $3.45BP/E –Yield 2.18%

KPIs & segments

Operating metrics and segments that drive Ashland's business

Ashland's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Ashland's fiscal year ends September 30 — Q3 FY26 = CQ2 2026 (calendar quarter).

Periods

Metric	Q3 FY26 CQ2 2026	Q2 FY26 CQ1 2026	Q1 FY26 CQ4 2025	Q4 FY25 CQ3 2025	Q3 FY25 CQ2 2025	Q2 FY25 CQ1 2025	Q1 FY25 CQ4 2024	Q4 FY24 CQ3 2024	Q3 FY24 CQ2 2024	Q2 FY24 CQ1 2024	Q1 FY24 CQ4 2023	Q4 FY23 CQ3 2023

Life Sciences($M)4	180	172	139	173	162	172	134	193	195	222	200	203
Europe($M)	71	68	49	61	60	69	50	69	65	72	63	68
Asia Pacific($M)	56	53	46	56	52	53	46	60	58	57	51	51
North America($M)	33	32	27	33	31	30	23	44	56	73	67	62
Latin America & Other($M)	20	19	17	23	19	20	15	20	16	20	19	22
Personal Care($M)4	155	150	123	151	147	146	134	161	175	169	129	146
Europe($M)	59	60	46	56	59	59	45	57	65	69	47	60
North America($M)	39	38	30	39	35	41	40	47	51	45	40	42
Asia Pacific($M)	38	33	31	34	34	30	31	34	37	31	25	21
Latin America & Other($M)	19	19	16	22	19	16	18	23	22	24	17	23
Specialty Additives($M)4	136	134	102	131	131	134	115	143	150	157	122	144
North America($M)	48	43	36	44	47	46	40	46	49	46	42	46
Europe($M)	48	47	32	48	48	48	34	50	55	63	40	52
Asia Pacific($M)	34	36	28	31	30	33	34	41	38	40	34	39
Latin America & Other($M)	6	8	6	8	6	7	7	6	8	8	6	7
Intermediates($M)4	37	35	31	33	33	37	33	36	36	40	33	37
North America($M)	24	25	19	21	21	25	23	27	24	27	25	28
Europe($M)	7	5	5	6	9	6	5	4	7	6	4	4
Asia Pacific($M)	4	3	5	4	2	4	3	4	4	6	3	3
Latin America & Other($M)	2	2	2	2	1	2	2	1	1	1	1	2

Life Sciences($M)	60	49	31	53	-321	54	28	57	58	66	48	49
Personal Care($M)	44	42	26	42	40	43	29	34	51	45	22	36
Specialty Additives($M)	18	8	10	22	-309	23	11	24	33	26	6	7
Intermediates($M)	4	5	1	5	7	2	6	10	9	12	10	3

Life Sciences($M)	45	35	17	39	-343	28	14	43	43	50	32	31
Personal Care($M)	29	27	11	26	25	28	11	14	31	25	2	14
Intermediates($M)	3	4	0	2	4	-1	3	7	6	9	7	0
Specialty Additives($M)	3	-7	-8	5	-345	7	-5	8	10	-18	-32	-12

Life Sciences($M)	74	63	45	66	59	55	43
Personal Care($M)	65	62	44	62	60	64	47
Specialty Additives($M)	26	16	14	26	8	28	16
Intermediates($M)	5	6	2	5	5	0	5

Life Sciences($M)	1,454	1,455	1,462	1,498	1,531	1,876	1,816	1,778	1,773	1,915	1,908	1,904
Specialty Additives($M)	964	988	990	1,020	1,048	1,355	1,323	1,516	1,500	1,526	1,556	1,580
Personal Care($M)	705	714	723	751	699	702	717	950	970	982	985	1,004
Intermediates($M)	107	107	110	116	118	119	124	127	124	135	132	136

31 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics

Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-07-29.

See a number that looks wrong?